العلاج من الخط الأول لالتهاب القنوات الصفراوية الأولي

References

DOI: 10.1002/hep.32117

Fibrates can be considered as off-label alternatives for patients with PBC and inadequate response to ursodeoxycholic acid, although fibrates are discouraged in patients with decompensated liver disease.